% alzhub.org library filter
% Source: https://alzhub.org/research?author=Rinne+JO&score_min=67
% 5 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{vandenberghe2016-27176461,
  author  = {Vandenberghe, R. and Rinne, J. O. and Boada, M. and Katayama, S. and Scheltens, P. and Vellas, B. and Tuchman, M. and Gass, A. and others},
  title   = {{Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0189-7},
  pmid    = {27176461},
  url     = {https://doi.org/10.1186/s13195-016-0189-7}
}

@article{stephen2020-32925045,
  author  = {Stephen, R. and Solomon, A. and Ngandu, T. and Levälahti, E. and Rinne, J. O. and Kemppainen, N. and Parkkola, R. and Antikainen, R. and others},
  title   = {{White Matter Changes on Diffusion Tensor Imaging in the FINGER Randomized Controlled Trial}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2020},
  doi     = {10.3233/jad-200423},
  pmid    = {32925045},
  url     = {https://doi.org/10.3233/jad-200423}
}

@article{lovestone2015-25537011,
  author  = {Lovestone, S. and Boada, M. and Dubois, B. and Hüll, M. and Rinne, J. O. and Huppertz, H. J. and Calero, M. and Andrés, M. V. and others},
  title   = {{A phase II trial of tideglusib in Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-141959},
  pmid    = {25537011},
  url     = {https://doi.org/10.3233/jad-141959}
}

@article{mummery2023-37095250,
  author  = {Mummery, C. J. and Börjesson-Hanson, A. and Blackburn, D. J. and Vijverberg, E. G. B. and De Deyn, P. P. and Ducharme, S. and Jonsson, M. and Schneider, A. and Rinne, J. O. and Ludolph, A. C. and Bodenschatz, R. and Kordasiewicz, H. and others},
  title   = {{Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial}},
  journal = {Nature Medicine},
  year    = {2023},
  doi     = {10.1038/s41591-023-02326-3},
  pmid    = {37095250},
  url     = {https://doi.org/10.1038/s41591-023-02326-3}
}

@article{blennow2012-22473769,
  author  = {Blennow, K. and Zetterberg, H. and Rinne, J. O. and Salloway, S. and Wei, J. and Black, R. and Grundman, M. and Liu, E. and others},
  title   = {{Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2012.90},
  pmid    = {22473769},
  url     = {https://doi.org/10.1001/archneurol.2012.90}
}